:: Library Catalog

Imagen de Portada

Guardado en:

Detalles Bibliográficos
Autor principal:	Mamoor, Shahan
Formato:	Recurso digital
Lenguaje:
Publicado:	Zenodo 2025
Acceso en línea:	https://doi.org/10.5281/zenodo.14876928
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

An intrinsic link between the EMT program and aging in human cells.
por: Mamoor, Shahan
Publicado: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: TM4SF4.
por: Mamoor, Shahan
Publicado: (2025)

Genes expressed in the CD4 + T lymphocyte.
por: Mamoor, Shahan
Publicado: (2025)

TSC22D4 gene activation in Crohn's Disease.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: PFKFB4.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: LILRA4.
por: Mamoor, Shahan
Publicado: (2025)

A comprehensive description of the circulating tumor cell: Fzd4/Fzd3.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: PTPN4.
por: Mamoor, Shahan
Publicado: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of lung metastasis: GRIK4.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
por: Mamoor, Shahan
Publicado: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
por: Mamoor, Shahan
Publicado: (2026)

LOC107984343, a TE differentiation-associated product.
por: Mamoor, Shahan
Publicado: (2026)

Aire is a component gene of the Th17 gene signature.
por: Mamoor, Shahan
Publicado: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
por: Mamoor, Shahan
Publicado: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
por: Mamoor, Shahan
Publicado: (2025)

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
por: Mamoor, Shahan
Publicado: (2026)

Ep300 activation defines a common epigenetic route in chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

Haglr, a HOXD antisense growth-associated long non-coding RNA with functions in lineage commitment in the human embryo.
por: Mamoor, Shahan
Publicado: (2026)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
por: Mamoor, Shahan
Publicado: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
por: Mamoor, Shahan
Publicado: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
por: Mamoor, Shahan
Publicado: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
por: Mamoor, Shahan
Publicado: (2025)

Importin 8 is activated in childhood brain cancer.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
por: Mamoor, Shahan
Publicado: (2025)

Telomerase control of Xist through Trf2.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PGP.
por: Mamoor, Shahan
Publicado: (2025)

Matrix metalloproteinases MMP1/MMP9 function in melanoma resistance.
por: Mamoor, Shahan
Publicado: (2025)

Phosphatase targeting in Luminal B breast cancer: PNKP.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: SRC.
por: Mamoor, Shahan
Publicado: (2025)

ABC transporter multi-drug resistance genes ("pumps") in humans with non-small cell lung cancer.
por: Mamoor, Shahan
Publicado: (2025)

HSC, CMP and CLP in mice.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MYO9B.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: NFATC1.
por: Mamoor, Shahan
Publicado: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: GDF5.
por: Mamoor, Shahan
Publicado: (2025)